|
|
|
| Analysis of constraint factors in the patent transformation of medical devices in Hubei Province |
| JIANG Yawei GAO Xiang XU Yanping ZHANG Wei FANG Bin ZUO Wanjun JIANG Xun |
| Reproductive Center, Renmin Hospital of Wuhan University, Hubei Province, Wuhan 430060, China |
|
|
|
Abstract Objective To analysis the constraint factors in the process of patent transformation of medical devices. Methods From March to July 2019, questionnaires were issued to patent holders, technical backbone of patent transformation enterprises (including incubation enterprises) and investment fund practitioners in 5 academic groups and 4 enterprises. The factors affecting the transformation platform and technology involved in the patent transformation of medical devices, the unit transformation environment, the difficulty of obtaining the patent product registration certificate, the capital situation, and the sales channels were investigated, and the data were sorted out to get the question outline. According to the judgment sampling method, 31 people from the above three categories were selected for interview, and the sequence of patent transformation process and force field analysis were used for analysis. Results A total of 170 questionnaires were issued and 158 valid answers were received. The problem focuses on high annual patent fee, difficulty in obtaining patent product registration certificate, lack of funds; lack of conversion conditions, poor sales, etc. Fifteen persons think the patent maintenance cost is higher, 15 persons lack of conversion platform and technology, 8 persons failing to crack down on counterfeit products, 5 persons whose products are not covered by the insurance, 5 persons with signature change of high quality patent, 4 persons with long time and high cost to obtain product production qualification, 4 people early participation in the fund withdrew. Conclusion For the successful transformation of medical device patents, it is necessary to improve the quality of patents and introduce various policies conducive to the transformation based on the experience of developed countries.
|
|
|
|
|
|
[1] 王平.青岛市北区：重奖科技创新赋能民营经济[N].青岛日报市北专刊，2019-6-13.
[2] 李顺德.知识产权公共教程[M].北京：中国人事出版社，2007：1.
[3] 丁朝阳.关于企业专利战略研究中几个问题的思考[J].法制博览，2019（7）：222.
[4] 蒋莉蓉.发明专利申请量连续8年居世界首位！我国从科技大国向科技强国迈进[EB/OL].[2019-07-23]. https：//china.huanqiu.com/article/9CaKrnKlITN
[5] 朱杰，张从昕.关于建立卫生行业专利技术转化服务体系的思考[J].中华医学科研管理，2015，28（3）：239-241.
[6] 黄祥国，江婷，向闱，等.湖北省产学研合作现状、问题与对策分析[J].科技创业月刊，2017（22）：86-88.
[7] 湖北省人民政府.《湖北省自主创新促进条例》解读[EB/OL]. [2016-08-01]. http：//www.hubei.gov.cn/zwgk/zcsd/201608/t20160801_873827.shtml
[8] 湖北省科技厅.湖北省科学技术厅关于深入推进科技创业的十条意见（鄂科技规[2015]1号）[EB/OL].[2015-05-21]. http：//www.hbstd.gov.cn/tzgg/wjtz/44928.htm
[9] 湖北省人民政府.湖北“新九条”推动科技人员走向企业[EB/OL].[2015-11-17]. http：//www.hubei.gov.cn/tzhb/touzi/lxhbtzzn/tzzn/201511/t20151117_750655.shtml
[10] 医疗器械注册管理办法（国家食品药品监督管理总局令第4号）[EB/OL].[2014-07-30].http：//www.gov.cn/gongbao/content/2014/content_2758500.htm
[11] Kiseleva V，Evstigneeva L. Transformation of Russian potential in the field of innovations：lessons from China [J]. Mezhdunarodnye Protsessy，2017，15（51）：186-201.
[12] 李雅莉，张兰，李林.医疗机构专利申报和成果转化现状及政府优惠政策分析[J].中国医院，2018，22（8）：39-41.
[13] 韩晓洁，兰玉坤，陈钊.医疗专利转化困境中医院和企业影响因素的分析[J].中国卫生事业管理，2017，（11）：878-880.
[14] 丁小宸.美国健康服务业发展研究[D].长春：吉林大学，2018：106-107.
[15] 上海市食品药品监督管理局.中国（上海）自由贸易试验区内医疗器械注册人制度试点工作实施方[EB/OL].2017-12-07.http：//www.medicalstrong.com/info.aspx?id=60
[16] 周博闻.美国健康服务业发展研究[D].长春：吉林大学，2019：70-71，102-103.
[17] 郭文姣.我国医疗器械产学研医合作创新管理策略研究[D].北京：协和医学院，2013：40-45.
[18] 陈敏.日本医疗器械审评审批机构简介[N].中国医药报，2019-2-26（008）.
[19] 陈敏，邓刚，刘静静.日本医疗器械审评审批信息公开制度的研究[J].中国医疗器械杂志，2018，42（5）：357-360.
[20] 付书科，刘敏，谭浩然.双创背景下武汉产学研合作模式探析[J].当代经济，2018（1）：70-71.
[21] Rafols I，Molas GJ，Castro ME，et al. Analysing innovation policy indicators through a functional approach：the aeronautic industry case1 [A]. 21st International Conference on Science and Technology Indicators （STI）[C]. 2016：139-148. |
|
|
|
